Highlights From ASRS – Retinal Vascular Disease
A curated ebook on ASRS 2023 with a focus on retinal vascular disease, featuring recent studies, findings, and opinions from thought leaders.
Read More
Ad Code: Eylea - ASRS 23 Display Banners Conference - Oct - 60771
Aflibercept 8 mg Provides Vision Gains With Fewer Injections in DME
Among patients with diabetic macular edema (DME) and neovascular age-related macular degeneration...
Read More
Racial & Ethnic Diversity Lacking in Diabetic Retinopathy Trials
“Jennifer Pinal, a co-author on this study and a current Latinx medical student from the community...
Read More
Aflibercept 8 mg Provides “Greater Therapeutic Benefit” in Neovascular AMD
Compared with 2 mg, aflibercept 8 mg administered at varying intervals was more effective, with...
Read More
Using OCTA Blood Flow Analysis to Detect Early Diabetic Retinopathy
Researchers have found a biomarker to detect early diabetic retinopathy, which involves evaluating...
Read More
Aflibercept 8 mg Vs 2 mg for Wet AMD: Safe & Better Outcomes
The objective of the Phase 3 PULSAR trial was to assess the efficacy and safety of intravitreal...
Read More
Varied Syringe Accuracy Affects Intravitreal Injection Safety
For a study, researchers delved into the accuracy and residual volume of commonly used syringes...
Read More
Elevating Diabetic Retinopathy Diagnosis: The Potential of OCTA Bloodflow Analysis
In a pivotal retrospective study, researchers explored the promise of quantitative bloodflow...
Read More
Promising Outcomes With Aflibercept for Diabetic Macular Edema: The PHOTON Trial
Researchers conducted a study to assess the effectiveness and safety of aflibercept at two...
Read More
ASRS Satellite Symposia
The live and hybrid satellite symposia listed below will take place in conjunction with the Annual...
Read More
ASRS Awards
ASRS Founders Award Johanna M. Seddon, MD, ScM, FARVO, FASRS, professor, interim chair and...
Read More
ASRS Schedule At A Glance
Check out the ASRS Schedule! Friday, July 28 International Symposium 1:00-2:00 PM Sub-Specialty...
Read More